跳至主要内容
临床试验/NCT01995461
NCT01995461终止不适用

Effectiveness of Bilateral Transforaminal Epidural Steroid Injections in Degenerative Lumbar Spinal Stenosis Patients With Neurogenic Claudication: A Prospective Outcome Study

Marshfield Clinic Research Foundation1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2013年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
26
试验地点
1
主要终点
Change From Baseline Pain Score at 6 Months

研究概览

简要总结

The most common forms of injection used for the treatment of degenerative lumbar spinal stenosis (DLSS) patients with neurogenic claudication (NC) are the caudal and inter-laminar epidural injections of anesthetic and steroid. Unilateral transforaminal epidural steroid injections (TESI) are also used to alleviate patients' symptoms of NC from DLSS, particularly in patients whose level of stenosis is L4-5 or higher. However, these unilateral injections do not cross the midline, so in cases of lower extremity pain and symptoms on both sides, a bilateral TESI would probably be more beneficial.

To date, there have not been any well designed prospective studies to determine the effectiveness of bilateral TESI below the level of stenosis in DLSS patients with NC. Therefore, the goal of this prospective, non-randomized case-series outcome study is to evaluate the effectiveness of BTESI in alleviating symptoms of NC, as well as improving function in patients with DLSS. The hypothesis is that BTESI at the level below the most stenotic segment of the central canal of the lumbar spine decreases symptoms of NC and improves function in patients with DLSS.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
40 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptoms of back/buttock/leg pain (NOT radicular pain) in a neurogenic claudicatory fashion, relieved by stooping or sitting down, for at least 3 months with no or poor response to conservative treatment (analgesics, NSAIDs, or physical therapy)
  • Patients with bilateral buttock and/or bilateral lower extremity pain in a neurogenic fashion with or without lower back pain
  • Radiologic documentation of degree of degenerative lumbar spinal stenosis (DLSS)
  • MRI/CT showing at least moderate central canal spinal stenosis (neuro-radiologist definition) with symptoms correlating with stenosis (symptoms of back/buttock/leg pain without unilateral radicular pain in a neurogenic claudicatory fashion, relieved by stooping or sitting down)
  • Patients choosing to receive BTESI as their next treatment option, following discussions with their spine doctor
  • Patients who can give informed consent, could tolerate the procedure, and who are able to understand and answer the forms and questionnaires properly.

排除标准

  • Radiologic spinal stenosis without symptoms of spinal stenosis
  • Symptoms of neurogenic claudication without at least moderate degree of radiologic spinal stenosis
  • Patients with specific lumbo-sacral radicular symptoms or radiculopathy (radicular pain secondary to a single nerve root compression/inflammation; usually follows a specific dermatome in lower extremities; unilateral radiculopathy either from disc herniation or lateral recess stenosis)
  • Patients with vascular claudication (pain in the legs secondary to arterial insufficiency)
  • Previous lumbo-sacral surgery
  • Any condition that does not allow the patient to stand and/or walk for any length of time (e.g., COPD, severe lung disease, etc.)
  • Patients with symptomatic hip joint pathology concurrent with spinal stenosis
  • A coexisting musculoskeletal condition that would negate functional improvement from the injection (e.g., severe Parkinson disease, hemiparesis, etc.)
  • Malignancy or infection to the spine
  • Another pain generating condition that would mask the improvement provided by the injection
  • Patients who had lumbar epidural steroid injections within the past six months
  • Significant psychologic diagnosis and/or dementia
  • Patients receiving workman's compensation benefit
  • Patients unable to give consent on their own, or who are not able to understand and answer the forms and questionnaires, or their answers will not be reliable.

研究组 & 干预措施

BTESI

Experimental

a prospective, non-randomized, case series investigating bilateral transforaminal epidural steroid injections (BTESI)

干预措施: bilateral transforaminal epidural steroid injections (Drug)

结局指标

主要结局

Change From Baseline Pain Score at 6 Months

时间窗: baseline (pre-1st injection) to 6 months post-1st injection

change from baseline (pre-1st injection) pain score, based on a numeric pain scale of 0-10(most severe pain), at 6 months post-1st injection

次要结局

  • Change From Baseline Swiss Spinal Stenosis Score at 6 Months(baseline (pre-1st injection) to 6 months post-1st injection)
  • Change From Baseline Oswestry Disability Index at 6 Months(baseline (pre-1st injection) to 6 months post-1st injection)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mustafa Farooque, MD

Medical Staff Physician/Clinician

Marshfield Clinic Research Foundation

研究点 (1)

Loading locations...

相似试验

Bilateral Transforaminal Epidural Steroid Injections... | 临床试验